SCHEMBL20735546

SCHEMBL20735546

c1ccc2c(c1)nc1sc3c(-c4ccc5c(c4)c4cccc6c4-c4c(cccc4c4ccccc45)c4ccccc4c4ccccc64)nccc3n12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 4/20 0.36
KDM4E B2RXH2 4/20 0.36
SMN1; SMN2 Q16637 8/20 0.35
NPC1 O15118 5/20 0.35
TP53 P04637 4/20 0.35
RAB9A P51151 4/20 0.35
KMT2A Q03164 4/20 0.35
MAPT P10636 4/20 0.35
POLB P06746 3/20 0.35
MEN1 O00255 3/20 0.35
LMNA P02545 2/20 0.35
HPGD P15428 5/20 0.34
ENPP1 P22413 1/20 0.32
MAPK1 P28482 2/20 0.32
TSHR P16473 1/20 0.32
HTT P42858 1/20 0.32
ALDH1A1 P00352 4/20 0.32
MAPK9 P45984 1/20 0.31
MAPK14 Q16539 1/20 0.31
PTP4A3 O75365 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20698250 0.94 HSD17B10 (0.39) HSD17B10KDM4ESMN1; SMN2NPC1TP53
SCHEMBL20735395 0.84 KDM4E (0.39) HSD17B10KDM4ESMN1; SMN2NPC1TP53
SCHEMBL20698249 0.79 HSD17B10 (0.41) HSD17B10KDM4ESMN1; SMN2NPC1TP53
SCHEMBL22929990 0.78 SMN1; SMN2 (0.37) HSD17B10KDM4ESMN1; SMN2NPC1TP53
SCHEMBL20735399 0.76 KDM4E (0.34) HSD17B10KDM4ESMN1; SMN2NPC1TP53
SCHEMBL20734347 0.74 MEN1 (0.33) HSD17B10KDM4ESMN1; SMN2NPC1TP53
SCHEMBL16432567 0.73 SMN1; SMN2 (0.50) HSD17B10KDM4ESMN1; SMN2NPC1TP53
SCHEMBL22100072 0.71 HSD17B10 (0.47) HSD17B10KDM4ESMN1; SMN2NPC1TP53
SCHEMBL22930023 0.70 SMN1; SMN2 (0.38) HSD17B10KDM4ESMN1; SMN2NPC1TP53
SCHEMBL20735557 0.70 ALOX5 (0.41) KDM4ESMN1; SMN2RAB9AMAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11349083-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2022-05-31 US disclosed
US-20190051843-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION 2019-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190051843-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES BMP4, CTCF, ORC3 HSD17B10 4335/4885KDM4E 1387/4885SMN1; SMN2 4355/4885
US-11349083-B2 Organic electroluminescent materials and devices BMP4, CTCF, ORC3 HSD17B10 4335/4885KDM4E 1387/4885SMN1; SMN2 4355/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.